The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s oncology molecular diagnostics market report forecasts the oncology molecular diagnostics market size to grow to $7.11 Billion by 2027, with a CAGR (compound annual growth rate) of more than 14%.

Learn More On The Oncology Molecular Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

Oncology Molecular Diagnostics Market Size Forecast
The global oncology molecular diagnostics market is expected to grow from $3.66 billion in 2022 to $4.19 billion in 2023 at a compound annual growth rate (CAGR) of 14.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The oncology molecular diagnostics market is expected to grow from $7.11 billion in 2027 at a CAGR of 14.2%.

North America held the largest oncology molecular diagnostics market share.

Key Oncology Molecular Diagnostics Market Driver ­– Rise In The Number Of Cancer Cases Globally
According to the American Cancer Society, there were 1.8 million new cases and 0.6 million cancer deaths in 2021 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the oncology molecular diagnostic market over the coming years.

Request for A Sample Of The Global Oncology Molecular Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3457&type=smp

Key Oncology Molecular Diagnostics Market Trend – Advancing Technology In Genomics
For instance, Roche Molecular Systems, Inc., a US-based company, developed Cobas EGFR Mutation Test for non-small cell lung cancer patients. This test is a real-time test that detects 42 mutations of the epidermal growth factor receptor (EGFR) gene, along with the resistant mutation of cancer. In June 2020, FDA approved Cobas EGFR Mutation Test.

Oncology Molecular Diagnostics Market Segment
1) By Product: Instruments, Reagents, Other Products
2) By Technology: Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies
3) By End User: Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End Users

Oncology Molecular Diagnostics Market Major Players and Strategies
Major players in the oncology molecular diagnostics market are Abbott Diagnostics, Becton Dickinson, Cepheid, Danaher Corporation, Beckman Coulter, Leica Biosystems, Gen-Probe (Hologic), Qiagen N.V., Roche Diagnostics, and Siemens Healthcare.

The Oncology Molecular Diagnostics Global Market Report 2023 covers regional data on oncology molecular diagnostics market size, oncology molecular diagnostics market trends and drivers, opportunities, strategies, and oncology molecular diagnostics market competitor analysis. The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The oncology molecular diagnostics refers to procedure for diagnosing cancers and related services. Molecular diagnostics are tests that diagnose genetic information, proteins, or related molecules and provide health or disease information.

View More Reports Related To The Oncology Molecular Diagnostics Market –
Cancer Diagnostics Global Market Report 2023
Microbiology Diagnostic Devices And Equipment Global Market Report 2023
Diagnostic Imaging Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: